Table 1 Demographic characteristics of chronic HCV patients and non-HCV patients
Chronic HCV patients (n = 128,967) | Non-HCV patients (n = 515,868) | |||
|---|---|---|---|---|
n | (%) | n | (%) | |
Male | 65,781 | (51.0) | 263,124 | (51.0) |
Age (years), median (range) | 70 | (18–107) | 70 | (18–109) |
Age category (years) | ||||
18–24 | 556 | (0.4) | 2224 | (0.4) |
25–29 | 779 | (0.6) | 3116 | (0.6) |
30–34 | 1388 | (1.1) | 5552 | (1.1) |
35–39 | 2095 | (1.6) | 8380 | (1.6) |
40–44 | 3252 | (2.5) | 13,008 | (2.5) |
45–49 | 4639 | (3.6) | 18,556 | (3.6) |
50–54 | 7008 | (5.4) | 28,032 | (5.4) |
55–59 | 9221 | (7.1) | 36,884 | (7.1) |
60–64 | 13,581 | (10.5) | 54,324 | (10.5) |
65–69 | 19,222 | (14.9) | 76,888 | (14.9) |
70–74 | 20,376 | (15.8) | 81,504 | (15.8) |
75–79 | 20,279 | (15.7) | 81,116 | (15.7) |
80–84 | 16,881 | (13.1) | 67,524 | (13.1) |
85–89 | 7525 | (5.8) | 30,100 | (5.8) |
≥ 90 | 2165 | (1.7) | 8660 | (1.7) |
Chronic HCV diseasea | ||||
Chronic hepatitis C | 85,282 | (66.1) | – | |
Hepatitis C | 42,802 | (33.2) | – | |
HCV-related cirrhosis | 11,533 | (8.9) | – | |
Hepatitis C virus infection | 2560 | (2.0) | – | |
Decompensated HCV-related cirrhosis | 645 | (0.5) | – | |
Compensated HCV-related cirrhosis | 434 | (0.3) | – | |
With treatment of HCV | 17,244 | (13.4) | – | |
DAA | 16,338 | (94.7) | – | |
Peginterferon + ribavirin | 906 | (5.3) | – | |
Mental and behavioural disorders due tob | ||||
Alcohol | 515 | (0.4) | 1114 | (0.2) |
Tobacco | 345 | (0.3) | 607 | (0.1) |
Psychoactive substance use | 137 | (0.1) | 135 | (0.0) |
Opioid use | 0 | (0.0) | 0 | (0.0) |
Co-infectionb | ||||
HIV | 336 | (0.3) | 167 | (0.0) |
HBV | 5368 | (4.2) | 4823 | (0.9) |
Hospital admissionc | 55,423 | (43.0) | 141,817 | (27.5) |
Total length of hospital admissions (days), median (range) | 18 | (1–678) | 13 | (1–684) |
Total number of hospital admissions | ||||
Once | 32,492 | (25.2) | 100,483 | (19.5) |
Twice or more | 22,931 | (17.8) | 41,334 | (8.0) |